-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Formycin A
Category | Human immunodeficiency Virus (HIV) |
CAS | 6742-12-7 |
Description | Formycin A is produced by the strain of Nocardia intriforma M4-C5. It has the activity of resistance to Salicornia, Pyricularia oryzae and Mole disease Phanerochaetehrysosporium of potato. |
Product Information
Synonyms | (1S)-1-(7-amino-1H-pyrazolo[4,3-d]pyrimidin-3-yl)-1,4-anhydro-D-ribitol; NSC 102811; BRN 0624229; 7-Amino-3-beta-D-ribofuranosyl-1H-pyrazolo(4,3-d)pyrimidine |
IUPAC Name | (2S,3R,4S,5R)-2-(7-amino-2H-pyrazolo[4,3-d]pyrimidin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol |
Molecular Weight | 267.24 |
Molecular Formula | C10H13N5O4 |
Canonical SMILES | C1=NC2=C(NN=C2C(=N1)N)C3C(C(C(O3)CO)O)O |
InChI | InChI=1S/C10H13N5O4/c11-10-6-4(12-2-13-10)5(14-15-6)9-8(18)7(17)3(1-16)19-9/h2-3,7-9,16-18H,1H2,(H,14,15)(H2,11,12,13)/t3-,7-,8-,9+/m1/s1 |
InChIKey | KBHMEHLJSZMEMI-KSYZLYKTSA-N |
Boiling Point | 709.5°C at 760 mmHg |
Melting Point | 141-142°C |
Purity | ≥ 97% |
Density | 1.771 g/cm3 |
Solubility | In vitro: 10 mM in DMSO |
Appearance | White Crystalline |
Application | Antineoplastic Agents |
Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
Complexity | 335 |
Exact Mass | 267.09675391 |
In Vitro | Formycin A (NSC 102811; 1 μM, 5 μM, 10 μM) antagonizes Zidovudine (AZT; a dideoxynucleoside chain terminator). |
PSA | 150.40000 |
Target | HIV; Nucleoside Antimetabolite/Analog; Antibiotic |
XLogP3-AA | -2.2 |